share_log

復星醫藥：董事會會議日期

FOSUN PHARMA: DATE OF BOARD MEETING

香港交易所 ·  Mar 12 05:27
Summary by Moomoo AI
復星醫藥宣布將於2024年3月26日（星期二）召開董事會會議，屆時將考慮及通過公司及其附屬公司截至2023年12月31日止年度的全年業績報告，並將討論建議的末期股息（如有）。此次會議將處理其他事宜。董事會成員包括執行董事吳以芳、王可心、關曉暉、文德鏞，非執行董事陳啟宇、姚方、徐曉亮、潘東輝，以及獨立非執行董事李玲、湯谷良、王全弟、余梓山。
復星醫藥宣布將於2024年3月26日（星期二）召開董事會會議，屆時將考慮及通過公司及其附屬公司截至2023年12月31日止年度的全年業績報告，並將討論建議的末期股息（如有）。此次會議將處理其他事宜。董事會成員包括執行董事吳以芳、王可心、關曉暉、文德鏞，非執行董事陳啟宇、姚方、徐曉亮、潘東輝，以及獨立非執行董事李玲、湯谷良、王全弟、余梓山。
FUSTAR PHARMACEUTICALS ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024, AT WHICH TIME THE COMPANY AND ITS SUBSIDIARIES WILL CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023, AND THE PROPOSED FINAL DIVIDEND (IF ANY) WILL BE DISCUSSED. Other matters will be dealt with at this meeting. The members of the Board of Directors include Executive Directors Wu Yifang, Wang Kechin, Guan Xiaoxin, Wen De Yung, Non-Executive Directors Chen Qiyu, Yao Fang, Xu Xiaoliang, Pan Donghui, and Independent Non-Executive Directors Li Ling, Tung Guan Liang, Wang Quan, Yu Zishan.
FUSTAR PHARMACEUTICALS ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024, AT WHICH TIME THE COMPANY AND ITS SUBSIDIARIES WILL CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023, AND THE PROPOSED FINAL DIVIDEND (IF ANY) WILL BE DISCUSSED. Other matters will be dealt with at this meeting. The members of the Board of Directors include Executive Directors Wu Yifang, Wang Kechin, Guan Xiaoxin, Wen De Yung, Non-Executive Directors Chen Qiyu, Yao Fang, Xu Xiaoliang, Pan Donghui, and Independent Non-Executive Directors Li Ling, Tung Guan Liang, Wang Quan, Yu Zishan.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more